期刊
SEMINARS IN LIVER DISEASE
卷 30, 期 2, 页码 160-177出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0030-1253225
关键词
ABC transporters; bile acids; bilirubin; cholestasis; enterohepatic circulation; multidrug resistance (associated) proteins; nuclear receptors; adaptation
资金
- Austrian Science Foundation [P18613-BO5, P19118-B05, SFB 3008]
- Austrian Ministry for Science
- Austrian Science Fund (FWF) [F 3008] Funding Source: researchfish
Although hereditary or acquired defects in hepatobiliary transporter systems cause or predispose to cholestasis, adaptive bile acid transporter changes can counteract cholestasis by reducing hepatocellular and systemic concentrations of retained cholephiles. An important level in the regulation of adaptive bile acid transporters and overflow pathways is mediated at the transcriptional level by nuclear hormone receptors. Moreover, therapeutic approaches targeting nuclear receptors in cholestasis may stimulate these adaptive changes and open a new perspective for the treatment of cholestatic liver diseases. This review gives a comprehensive overview on bile acid transporters in the enterohepatic circulation and their adaptive changes in response to cholestasis as well as the regulatory networks underlying these adaptive mechanisms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据